On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88.

PomDoctor went public on the Nasdaq Stock Exchange on October 8, Eastern Time. The stock surged nearly 25% during intraday trading and closed up 0.75% on its IPO debut day.

The company completed its IPO by issuing 5 million American Depositary Shares (ADS) at a price of $4 per share, which was at the lower end of the $4-6 pricing range. The offering raised a total of $20 million.

As of December 31, 2024, the company had accumulated over 212,800 contracted physicians, issued more than 3 million prescriptions, and served 699,000 transactional patients (defined as patients who generated service consumption).

Joseph Stone Capital served as the sole bookrunner for the IPO transaction.